Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.
Publication
, Journal Article
Rutherford, SC; Yin, J; Pederson, LD; Blum, KA; Martin, P; Jung, S-H; Grant, B; Rosenbaum, C; Cheson, BD; Bartlett, NL; Mandrekar, SJ; Leonard, JP
Published in: Blood Adv
March 26, 2024
Duke Scholars
Published In
Blood Adv
DOI
EISSN
2473-9537
Publication Date
March 26, 2024
Volume
8
Issue
6
Start / End Page
1464 / 1468
Location
United States
Related Subject Headings
- Rituximab
- Progression-Free Survival
- Lymphoma, Follicular
- Humans
- Diagnostic Imaging
- Antibodies, Monoclonal, Murine-Derived
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rutherford, S. C., Yin, J., Pederson, L. D., Blum, K. A., Martin, P., Jung, S.-H., … Leonard, J. P. (2024). Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma. Blood Adv, 8(6), 1464–1468. https://doi.org/10.1182/bloodadvances.2023012090
Rutherford, Sarah C., Jun Yin, Levi D. Pederson, Kristie A. Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, et al. “Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.” Blood Adv 8, no. 6 (March 26, 2024): 1464–68. https://doi.org/10.1182/bloodadvances.2023012090.
Rutherford SC, Yin J, Pederson LD, Blum KA, Martin P, Jung S-H, et al. Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma. Blood Adv. 2024 Mar 26;8(6):1464–8.
Rutherford, Sarah C., et al. “Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.” Blood Adv, vol. 8, no. 6, Mar. 2024, pp. 1464–68. Pubmed, doi:10.1182/bloodadvances.2023012090.
Rutherford SC, Yin J, Pederson LD, Blum KA, Martin P, Jung S-H, Grant B, Rosenbaum C, Cheson BD, Bartlett NL, Mandrekar SJ, Leonard JP. Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma. Blood Adv. 2024 Mar 26;8(6):1464–1468.
Published In
Blood Adv
DOI
EISSN
2473-9537
Publication Date
March 26, 2024
Volume
8
Issue
6
Start / End Page
1464 / 1468
Location
United States
Related Subject Headings
- Rituximab
- Progression-Free Survival
- Lymphoma, Follicular
- Humans
- Diagnostic Imaging
- Antibodies, Monoclonal, Murine-Derived
- 3201 Cardiovascular medicine and haematology